Biomarker analysis of patients with follicular lymphoma treated with ibrutinib in the phase 2 DAWN study

Saved in:
Bibliographic Details
Published in:Hematological oncology 2017-06, Vol.35 (S2), p.210-211
Main Authors: Fowler, N., Gopal, A.K., Schuster, S.J., Trotman, J., Hess, G., Hou, J., Yacoub, A., Lill, M., Martin, P., Vitolo, U., Spencer, A., Radford, J., Jurczak, W., Morton, J., Osmanov, D., Caballero, D., Deshpande, S., Vermeulen, J., Damle, R., Schaffer, M., Balasubramanian, S., Cheson, B., Salles, G.
Format: Article
Language:English
Subjects:
Lymphoma
Patients
Targeted cancer therapy
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:
ISSN:0278-0232
1099-1069
DOI:10.1002/hon.2438_75